REFERENCES
1. Daruich A, Matet A, Moulin A, et al. Mechanisms of macular edema:
Beyond the surface. Prog Retin Eye Res . 2018;63:20-68.
2. Carreira AR, Marques N, Carreira P, et al. Safety of intravitreal
triamcinolone and its impact on optic nerve morphology in patients
treated for diabetic macular edema. Eur J Ophthalmol .
2022;32(3):1596-1601.
3. Vujosevic S, Midena E. Controversies in Pharmacological Treatment of
Inflammatory Component of Macular Edema. Curr Pharm Des .
2015;21(32):4688-93.
4. Golan S, Loewenstein A. Surgical treatment for macular edema.Semin Ophthalmol . Jul 2014;29(4):242-56.
5. Tang B, Wang X, Luo Y, Li Z, He Y. Efficacy and Safety of
Intravitreal Injection of Triamcinolone Acetonide and Conbercept for
Intraocular Lens after Cataract Surgery. Evid Based Complement
Alternat Med . 2022;2022:5606343.
6. Huang L, Zhang Z, Yao T, Gao X, Dan Y, He Y. The 100 top-cited
articles in macular edema from 1950 to 2020. Semin Ophthalmol .
2022;37(2):203-207.
7. Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for
the Management of Retinal Vein Occlusion by the European Society of
Retina Specialists (EURETINA). Ophthalmologica .
2019;242(3):123-162.
8. Chhablani J, Wong K, Tan GS, et al. Diabetic Macular Edema Management
in Asian Population: Expert Panel Consensus Guidelines. Asia Pac J
Ophthalmol (Phila) . 2020;9(5):426-434.
9. Valdes LM, Sobrin L. Uveitis Therapy: The Corticosteroid Options.Drugs . 2020;80(8):765-773.
10. Jea SY, Byon IS, Oum BS. Triamcinolone-induced intraocular pressure
elevation: intravitreal injection for macular edema and posterior
subtenon injection for uveitis. Korean J Ophthalmol .
2006;20(2):99-103.
11. Young S, Larkin G, Branley M, et al. Safety and efficacy of
intravitreal triamcinolone for cystoid macular oedema in uveitis.Clin Experiment Ophthalmol . 2001;29(1):2–6 .
12. Ibrahim MG, Salman A, Said AA, et al. Efficacy of posterior
sub-tenon’s capsule injection compared to intravitreal injection of
triamcinolone acetonide for treatment of diabetic macular edema: A
systematic review and meta-analysis. Egypt Retin J.2021;8(1):2347-5617.
13. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension
statement for reporting of systematic reviews incorporating network
meta-analyses of health care interventions: checklist and explanations.Ann Intern Med . (2015) 162:777–84.
14. Higgins JP, Savović J, Page MJ, et al. Chapter 8: Assessing risk of
bias in a randomized trial. Cochrane handbook for systematic reviews of
interventions version 6.1 (updated September 2020). The Cochrane 15
Collaboration, 2020. Available at:
https://training.cochrane.org/handbook/current/chapter-08/.
15. Brignardello-Petersen R, Florez ID, Izcovich A, et al. GRADE
approach to drawing conclusions from a network meta-analysis using a
minimally contextualised framework. BMJ . 2020; 371: m3900.
16. Hultcrantz M, Rind D, Akl EA, et al. The GRADE Working Group
clarifies the construct of certainty of evidence. J Clin
Epidemiol . 2017;87:4–13.
17. Zeng L, Brignardello-Petersen R, Hultcrantz M, et al. GRADE
guidelines 32: GRADE offers guidance on choosing targets of GRADE
certainty of evidence ratings. J Clin Epidemiol . 2021;137:
163–175.
18. Multinma: Bayesian Network Meta-Analysis of Individual and Aggregate
Data [program]. R package version 4.1.3 version (2020).
19. Greco T, Landoni G, Biondi-Zoccai G, et al. A Bayesian network
meta-analysis for binary outcome: how to do it. Stat Methods Med
Res . 2016;25:1757–1773.
20. Valkenhoef GV, Dias S, Ades AE, et al. Automated generation of
node-splitting models for assessment of inconsistency in network
meta-analysis. Res Synth Methods. 2016;7:80–93 .
21. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical
summaries for presenting results from multiple-treatment meta-analysis:
an overview and tutorial. J Clin Epidemiol . 2011;64:163–71.
22. Abdelshafy TA, Tawfik ST, Anany EM, et al. A Randomized Trial
Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone
Acetonide in Refractory Diabetic Macular Edema due to Epiretinal
Membrane. J Ophthalmol . 2022;2022:7947710.
23. Bonini-Filho MA, Jorge R, Barbosa JC, et al. Intravitreal injection
versus sub-Tenon’s infusion of triamcinolone acetonide for refractory
diabetic macular edema: a randomized clinical trial. Invest
Ophthalmol Vis Sci. 2005;46(10):3845-3859.
24. Cardillo JA, Melo LA, Jr., Costa RA, et al. Comparison of
intravitreal versus posterior sub-Tenon’s capsule injection of
triamcinolone acetonide for diffuse diabetic macular edema.Ophthalmology . 2005;112(9):1557-1563.
25. El-Sayed S, Ellakwa AA, Badawi NM, et al. Intravitreal versus
subtenon injection of triamcinolone acetonide for diabetic macular
edema. Menoufia Med J. 2014;27:636–664.
26. Gillies MC, McAllister IL, Zhu M, et al. Pretreatment with
intravitreal triamcinolone before laser for diabetic macular edema:
6-month results of a randomized, placebo-controlled trial. Invest.
Ophthalmol Vis Sci . 2010;51(5):2322-2328.
27. Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of
triamcinolone for macular edema associated with branch retinal vein
occlusion. American journal of ophthalmology . Jun
2005;139(6):972-82.
28. Li SY, Miao L, Chen H, et al. Efficacy and safety of combination
treatment with triamcinolone acetonide retrobulbar injection and
panretinal photocoagulation in diabetic macular edema. [Chinese].J Jilin Univer Med Edi. 2014;40(6):1289-1292.
29. Luo D, Zhu B, Zheng Z, et al. Subtenon Vs Intravitreal Triamcinolone
injection in Diabetic Macular Edema, A prospective study in Chinese
population. Pak J Med Sci . 2014;30(4):749-754.
30. Marey H, Ellakwa AF. Intravitreal bevacizumab alone or combined with
triamcinolone acetonide as the primary treatment for diabetic macular
edema. Clin Ophthalmology . 2011;5:1011-6.
31. Moon J, Kim M, Sagong M. Combination therapy of intravitreal
bevacizumab with single simultaneous posterior subtenon triamcinolone
acetonide for macular edema due to branch retinal vein occlusion.Eye (London, England) . 2016;30(8):1084-1090.
32. Rakhee A, Ajay A, Sagdeo M. Effect of combined Intravitreal
Injections of Bevacizumab and Triamcinolone Acetonide vs intravitreal
Bevacizumab in Diffuse Diabetic Macular Edema. J Med Dent Sci.2014(13):01-06.
33. Saleh MA, Abdelmoneim M, Fahmy H, et al. Posterior subtenon versus
intravitreal triamcinolone acetonide injection for the treatment of
diabetic macular edema. Curr Med Res Pract . 2017;2(2):141.
34. Soliman Mohamed A, Hamed AA, Nehad T, Islam M, Metawee AA.
Comparison between the effects of intravitreal and posterior subtenon
injection of triamcinolone acetonide for treatment of diabetic macular
edema. Benha Med J.2018;35:13-19.
35. Takata C, Messias A, Folgosa MS, et al. Intravitreal injection
versus subtenon infusion of triamcinolone acetonide during cataract
surgery in patients with refractory diabetic macular edema.Retina. 2010;30(4):562-569.
36. Wickremasinghe SS, Rogers SL, Gillies MC, et al. Retinal vascular
caliber changes after intravitreal triamcinolone treatment for diabetic
macular edema. Invest Ophthalmol Vis Sci. 2008;49(11):4707-4711.
37. Zakaria YG, Salman AG, Said AMA, et al. Suprachoroidal versus
Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic
Macular Edema. Clin Ophthalmol. 2022;16:733-746.
38. Chhablani J, Wong K, Tan GS, et al. Diabetic Macular Edema
Management in Asian Population: Expert Panel Consensus Guidelines.Asia Pac J Ophthalmol (Phila) . 2020;9(5):426-434.
39. American Diabetes Association Professional Practice Committee
(2022). 12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical
Care in Diabetes-2022. Diabetes Care . 2022; 45(Suppl 1),
S185-S194.
40. Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines
for the Management of Retinal Vein Occlusion by the European Society of
Retina Specialists (EURETINA). Ophthalmologica.2019;242(3),123-162.
41. Yuksel-Elgin C, Elgin C. Intraocular pressure elevation after
intravitreal triamcinolone acetonide injection: a Meta-analysis.Int J Ophthalmol . 2016 Jan 18;9(1):139-144.
42 Wykoff CC, Khurana RN, Lampen
SIR, et al. Suprachoroidal triamcinolone acetonide for diabetic macular
edema: the HULK trial. Ophthalmol Retina . 2018;2:874–877.
43 Barakat MR, Wykoff CC,
Gonzalez V, et al. Suprachoroidal CLS-TA plus intravitreal aflibercept
for diabetic macular edema: a randomized, double-masked,
parallel-design, controlled study. Ophthalmol Retina .
2021;5(1):60–70.
44 Maggio E, Mete M, Polito A, et al. Retrobulbar triamcinolone for
inflammatory choroidal neovascularization in pregnancy. BMC
Ophthalmol . 2020;20(1):483.
45 Grzybowski A, Kanclerz P. The Role of Steroids and NSAIDs in
Prevention and Treatment of Postsurgical Cystoid Macular Edema.Curr Pharm Des . 2018;24(41):4896-4902.
46 Wykrota AA, Abdin AD, Munteanu C, et al. Incidence and treatment
approach of intraocular pressure elevation after various types of local
steroids for retinal diseases. Graefes Arch Clin Exp Ophthalmol.2023;